Position in ANVS
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$181,334
-$100,019 QoQ
Shares Held
81,316
0.0% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $38,062,980 across 57 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,218 | $6,069,041 | |
| 2 | INCY |
Incyte Corp
|
50,561 | $5,731,591 | |
| 3 | EXEL |
Exelixis, Inc.
|
84,634 | $4,604,933 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,333 | $2,078,255 | |
| 5 | MRNA |
Moderna, Inc.
|
25,205 | $1,765,104 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
5,380 | $1,296,414 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
20,198 | $1,155,727 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
11,908 | $1,035,397 |
All Filings in ANVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $181,334 | 81,316 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $281,353 | 81,316 | Shares | Sole | 2026-01-26 | |
| 2025-06-30 | $198,155 | 91,316 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $146,724 | 97,816 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $495,535 | 98,516 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $215,202 | 26,700 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $124,992 | 21,700 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $264,180 | 22,200 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $415,140 | 22,200 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $390,988 | 41,200 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $605,896 | 42,400 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $661,089 | 42,900 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $579,504 | 43,150 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $274,000 | 20,000 | Shares | Sole | 2022-10-31 | |
| No filing history on record for this holder in this stock. | ||||||